MyJournals Home  

RSS FeedsA phase Ib dose-escalation and expansion study of the oral MEK inhibitor pimasertib and PI3K/MTOR inhibitor voxtalisib in patients with advanced solid tumours (British Journal of Cancer)

 
 

14 november 2018 05:00:11

 
A phase Ib dose-escalation and expansion study of the oral MEK inhibitor pimasertib and PI3K/MTOR inhibitor voxtalisib in patients with advanced solid tumours (British Journal of Cancer)
 




 
87 viewsCategory: Oncology
 
Addendum: Low-value approvals and high prices might incentivize ineffective drug development (Nature Clinical Practice Oncology)
Fibroblast growth factor 21 as a circulating biomarker at various stages of colorectal carcinogenesis (British Journal of Cancer)
 
 
blog comments powered by Disqus


MyJournals.org
The latest issues of all your favorite science journals on one page

Username:
Password:

Register | Retrieve

Search:

Oncology


Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures News Tweets Nachrichten